Applying technical requirements of ISO/IEC 17025:2005 in the Zoonotic diseases testing laboratory. Discussion on the challenges M.A Motaung.

Slides:



Advertisements
Similar presentations
Biosafety in Microbiologic and Biomedical Laboratories The University of Texas at Tyler IACUC Education and Training *Note: Content not specific to UT.
Advertisements

Biological Laboratory Safety Additional Information.
Requirements for and Challenges associated with BSL4 laboratories Dr Greg Smith Microbiological Security Manager Australian Animal Health Laboratory Geelong,
Kenya AIDS Vaccine Initiative
MARKETS AND ABATTOIRS The construction sites should be free of nuisance conditions, contamination, should have available adequate water supply for cleaning.
CDC/NIH Vertebrate Animal Biosafety Level Criteria ► For all Animal Biosafety Levels (1 - 4)  IACUC Approval  Authorized access to facilities  Animal.
BIOLOGICAL HAZARDS RISK ASSESSMENT
UC Davis Safety Services Monthly Safety Spotlight April 2010: Chemical and Laboratory Safety Safety Discussion Topics Critical Questions to Ask Laboratory.
CHEMICAL CARCINOGENS CHEMICAL CARCINOGENS. What is a Chemical Carcinogen?  Any chemical compound which has been shown to cause cancer in humans or in.
Testing Mason Pond. World Water Monitoring Challenge Kit.
Occupational Animal Exposure Both research and non-research animals have the potential to cause injury, transmit zoonotic diseases, and/or cause allergic.
An Introduction to Biological Safety Dr. A. Mantalaris Biological Safety Officer (ACE 515, Tel: x45601)
IFSQN CODEX and Good Manufacturing Practice Training Guide.
Bovine Spongiform Encephalopathy Luke VanNatter Carrie Pell Amy Richwine Scott Inskeep Kristina Anderson.
Mad Cow Disease. Effects of Mad Cow disease Mad cow disease, or bovine spongiform encephalopathy (BSE), is a fatal brain disorder that occurs in cattle.
Lesson 3 Good Production Practice #3 Use Antibiotics Responsibly.
Laboratory Management - 1
Occupational Safety and Health Administration (OSHA) Training BLOOD BORNE PATHOGENS 2/26/2014.
Standard Operating Procedures.  To understand: › The purpose of having SOP’s and how they affect the daily workings of laboratories.  To discuss: ›
Technical requirements:
O PERATING A BSL-3 F ACILITY IN K OREA T HE IVI E XPERIENCE INTERNATIONAL WORKSHOP ON ANTICIPATING BIOSECURITY CHALLENGES OF THE GLOBAL EXPANSION OF HIGH.
Bioterrorism MLAB 2434: Microiology Keri Brophy-Martinez.
8.02 Aseptic Techniques Implement aseptic technique to maintain equipment Images courtesy of google images.
Risk Assessment. Risk As defined by Kaplan and Garrick, risk analysis consists of answering three specific questions: what can happen? what is the chance.
BIOSAFETY Presented by: Leonard LaFazia. Introduction Development of Biosafety Practices Meyer and Eddie 74 lab associated brucellosis infections.
Safety. Four Simple Questions What are the hazards? What are the hazards? What are the worst things that could happen? What are the worst things that.
Environmental Sampling and Fieldwork Scientific work done outside the lab – on campus or off site Field trip policies and releases apply Additional precautions.
Introduction to Biohazards: Risk Management
Discuss the major characteristics of the four Biosafety Levels. Define “Risk Group” and give an example of each. Discuss how Risk Groups are used in conjunction.
Safety organization and training. The biosafety officer and biosafety committee A safety policy, A safety manual, and Supporting programmes for their.
United States Army Medical Research Institute of Infectious Diseases KYLE MELLING.
Improving Tuberculosis Infection Control
SAFETY IN MEDICAL LAB.
52 Table 1. Summary of Recommended Biosafety Levels for Infectious Agents. Biosafety Level Agents Practices Safety Equipment (Primary Barriers) Facilities.
BIOSAFETY LEVEL 2 AWARENESS TRAINING UW Stout Laboratory Safety Biological Safety.
Current Outbreaks Mike Kim, Matt Schilling, Kevin Cho, Nikilesh Kannan.
Ebola preparedness and Response in Lao PDR. Outline Objective The preparedness contingency plan Phase 1: Preparedness Phase 2: Contingency for response.
Formaldehyde. Regulation v Regulated areas 1a Regulation v Signs and markings 1b.
MAD COW DISEASE Anna Hoffmann. What is it?  Mad cow disease, or bovine spongiform encephalopathy (BSE), is a transmissible, slowly progressive fatal.
Most Common Deficiencies Cheryl O. Morton Managing Director, AIHA Laboratory Accreditation Programs, LLC.
Handling and Disposal of Infectious Wastes
The IBC is: The Institutional Biosafety Committee (aka Biohazards Committee)
Private Water Supplies Dr Simon Padfield Consultant in Communicable Disease Control North Yorkshire and Humber Health Protection Unit.
CARING FOR RESEARCH ANIMALS. Scientists try to reduce any pain or distress to animals. Animals that are treated well provide the normal biological & behavioral.
USP 800 Implementation in a Community Oncology Practice
National Food Control Systems
Managing waterborne pathogens in public swimming pools:
Outbreak Investigations
Farm BIosecurity.
By: Smarika Rijal and GaEun Kim
Created by: Alexandrea, Erika, Menna and Tia
Diseases Std: 8th . Sub: General Science.
Bacteria Cultures Biotechnology II.
Laboratory Biosafety and Biosecurity
Copyright © 2017 American Academy of Pediatrics.
Working with Biological Hazards
Bovine Spongiform Encephalopathy Variant Creutzfeldt-Jakob disease
Mad Cow Disease What it means, how it is caused, the misconceptions, and its terrible effects.
Employment Food Safety Training Program
BSL-1 Laboratory BIOHAZARD
Laboratory Safety Training for Contractors
How can eating behaviors negatively impact our health?
Technical requirements:
EBOLA VIRUS DISEASE Joseph P. Iser, MD, DrPH, MSc Southern Nevada Health District.
Diagnosed Food Handlers
Good Laboratory Practices
Lab Tech.
Tuberculosis.
Care of Research Animals
Animal Care Facilities at the Babraham Institute
Presentation transcript:

Applying technical requirements of ISO/IEC 17025:2005 in the Zoonotic diseases testing laboratory. Discussion on the challenges M.A Motaung

Introduction Laboratory facilities are designated as basic – Biosafety Level (BSL1& 2), containment (BSL 3) and maximum containment (BSL4). Biological Safety Levels are a series of protections relegated to the activities that take place in particular biological labs. Biosafety level designations are based on the design features, construction, containment facilities, equipment, practices and operational procedures required for working with agents from the various risk groups.

Introduction Laboratory testing for non-infectious agents that pose a minimal potential threat to laboratory workers and the environment are generally considered BSL 1 (Escherichia coli) the lowest biosafety lab level.

Introduction A laboratory testing for potentially (zoonotic disease)deadly infectious agents e.g. Bovine Spongiform Encephalopathy (BSE) disease is designated as BSL3.

E.coli infection & symptoms Escherichia coli (E. coli) is a type of bacteria that normally live in the intestines of people and animals. Some types of E. coli can cause intestinal infection. Symptoms of intestinal infection include diarrhoea, abdominal pain, and fever. More severe cases can lead to bloody diarrhoea, dehydration, or even kidney failure. Contaminated food or water.

E.coli: Treatment Proper food preparation and good hygiene can greatly decrease the chances of developing an intestinal infection. Most cases of intestinal E. coli infection can be treated at home. Symptoms generally resolve within few days to a week.

BSE Disease Bovine Spongiform Encephalopathy. Commonly known as ‘Mad cow disease”. Affects the nervous system of the adult cattle. Has a long incubation period: Signs -four to six years. Zoonotic disease: can infect humans (consumption of milk, brain and spinal cord). Can be detected by post-mortem brain examination.

BSE symptoms and treatment Symptoms of BSE in cattle and humans are: Disorientation, Staring at imaginary objects, Decreased milk production in cattle, Loss of weight despite continued appetite. It is fatal in animals and human: No treatment.

Aim and objectives To highlight the challenges associated with introduction, implementation and maintenance of internationally recognised quality standard (ISO 17025) in laboratories testing for zoonotic diseases.

Study design BSL 3: BSE testing laboratory was compared to BSL 1: E.coli testing laboratory with respect to technical requirements Personnel, Accommodation & environmental monitoring, Sample testing and validation, Equipment.

Personnel (BSL 3)

Personnel BSL3 BSL1 Training and competency declaration procedures lengthy: 1 year. Entering and exiting the lab: red and green lights Showering. Training and competency declaration procedures: 3 months. Entering and exiting the laboratory normally No showering.

Personnel BSL 3 Laboratory BSL1 Laboratory

Personnel BSL3 BSL1 Uncomfortable. Comfortable. Special suits which covers the neck, arms, and legs, goggles & masks. Medical surveillance: vaccination to boost titre (BSE). Comfortable. Normal lab coat and gloves. No routine vaccinations.

Accommodation and environmental monitoring BSL3 BSL1 Negative pressure. Access restricted from untrained personnel/visitors. Vaccination of visitors. Room temperature. Personnel and visitors can access the laboratory. No vaccination of visitors.

Sample testing & validation BSL3 BSL1 Positive samples not easy to obtain for testing (SA free of BSE). Validation as per requirements not possible. Not all validation parameters established. Positive samples easy to obtain. Validation as per requirements. Validation parameters established.

Sample testing & validation BSL3 BSL1 Application import permit (PT/positive samples). Autoclave the samples after testing and incinerate. No application of import permit. Incinerate after testing.

Equipment BSL3 BSL1 Shut down during calibration & repairs. Schedule of calibration aligned with shutdown. Turn around time affected. No shut down during calibration & repairs. Calibration done anytime and as per schedule. Turn around time not affected.

Equipment BSL3 BSL1 Training of technicians calibrating equipment on access and exit of the facility (safety). Vaccination of technicians calibrating equipment. No training provided for technicians calibrating equipment (access and exit of the facility. No vaccination.

Conclusion & Recommendations It is important to know the differences in biosafety levels and their corresponding safety requirements. It has been observed that there are differences between laboratories testing for diseases classified as BSL 1 and BSL 3. Clauses such as 5.2; 5.3; 5.4 and 5.5 of the ISO/IEC 17025 are regarded as strenuous and challenging to implement in BSL 3 due to costs and risks in relation to BSL1.

Conclusion & Recommendations It is feasible to comply with ISO 17025 requirements in BSL1 and BSL3 laboratories. The procedures should be properly followed to avoid infections and to ensure containment of the diseases and regular medical surveillance monitoring to effectively ensure and assure quality of results produced without compromising personnel’s health.

Conclusion & Recommendations It is recommended that personnel working in BSL3 be compensated for discomfort to ease the burden posed by the biosecurity and biosafety requirements.

Acknowledgements DAFF ARC BSE and Microbiology Staff Dr Gcebe and Dr Sabeta

???